Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
4 "Phenotype"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Review Article
Miscellanenous
Cushing Syndrome Associated Myopathy: It Is Time for a Change
Martin Reincke
Endocrinol Metab. 2021;36(3):564-571.   Published online June 18, 2021
DOI: https://doi.org/10.3803/EnM.2021.1069
  • 4,837 View
  • 175 Download
  • 16 Web of Science
  • 15 Crossref
AbstractAbstract PDFPubReader   ePub   
Cushing syndrome is the result of excessive levels of glucocorticoids. Endogenous Cushing syndrome is rare with an incidence of two to three cases per million per year. Clinically, the presentation consists of a characteristic phenotype including skin symptoms and metabolic manifestations. A frequent co-morbidity with high impact on quality of life is Cushing syndrome associated myopathy. It characteristically affects the proximal myopathy, impairing stair climbing and straightening up. The pathophysiology is complex and involves protein degradation via the forkhead box O3 (FOXO3) pathway, intramuscular fat accumulation, and inactivity-associated muscle atrophy. Surgical remission of Cushing syndrome is the most important step for recovery of muscle function. Restoration depends on age, co-morbidities and postoperative insulin-like growth factor concentrations. At average, functionality remains impaired during the long-term compared to age and sex matched control persons. Growth hormone therapy in individuals with impaired growth hormone secretion could be an option but has not been proved in a randomized trial.

Citations

Citations to this article as recorded by  
  • Long-Term Consequences of Cushing Syndrome: A Systematic Literature Review
    Soraya Puglisi, Anna Maria Elena Perini, Cristina Botto, Francesco Oliva, Massimo Terzolo
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e901.     CrossRef
  • The Link between Mitochondrial Dysfunction and Sarcopenia: An Update Focusing on the Role of Pyruvate Dehydrogenase Kinase 4
    Min-Ji Kim, Ibotombi Singh Sinam, Zerwa Siddique, Jae-Han Jeon, In-Kyu Lee
    Diabetes & Metabolism Journal.2023; 47(2): 153.     CrossRef
  • Intelligent Systems for Muscle Tracking: A Review on Sensor‐Algorithm Synergy
    Arjun Putcha, Tien Nguyen, Regina Smith, Rachel Choffin, Wubin Bai
    Advanced Intelligent Systems.2023;[Epub]     CrossRef
  • Sarcopenia in youth
    Han Na Jung, Chang Hee Jung, You-Cheol Hwang
    Metabolism.2023; 144: 155557.     CrossRef
  • Cushing Syndrome
    Martin Reincke, Maria Fleseriu
    JAMA.2023; 330(2): 170.     CrossRef
  • Musculoskeletal complications of Cushing syndrome
    Dorota Leszczyńska, Alicja Szatko, Lucyna Papierska, Wojciech Zgliczyński, Piotr Glinicki
    Rheumatology.2023; 61(4): 271.     CrossRef
  • Circulating myomiRNAs as biomarkers in patients with Cushing’s syndrome
    C. Pivonello, R. Patalano, C. Simeoli, T. Montò, M. Negri, F. Amatrudo, N. Di Paola, A. Larocca, E. M. Crescenzo, R. Pirchio, D. Solari, C. de Angelis, R. S. Auriemma, L. M. Cavallo, A. Colao, R. Pivonello
    Journal of Endocrinological Investigation.2023; 47(3): 655.     CrossRef
  • Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing's syndrome
    Frederick Vogel, Leah Braun, Stephanie Zopp, Elisabeth Nowak, Jochen Schreiner, Irina Benz, German Rubinstein, Heike Künzel, Katrin Ritzel, Matthias Kroiss, Jürgen Honegger, Felix Beuschlein, Katharina Schilbach, Daniel Teupser, Martin Bidlingmaier, Marti
    European Journal of Endocrinology.2023; 188(4): 375.     CrossRef
  • An odd case of immune-mediated necrotizing myopathy, complicated with sagittal, transverse and sigmoid sinus thrombosis
    Andreea Trandafir, Violeta Claudia Bonjincă, Delia Tulba, Gelu Onose
    Balneo and PRM Research Journal.2023; 14(Vol.14, no): 630.     CrossRef
  • Morbidität und Mortalität beim Cushing-Syndrom
    Frederick Vogel, Leah Braun, Martin Reincke
    Der Internist.2022; 63(1): 34.     CrossRef
  • Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside
    Vittoria Favero, Arianna Cremaschi, Chiara Parazzoli, Alberto Falchetti, Agostino Gaudio, Luigi Gennari, Alfredo Scillitani, Fabio Vescini, Valentina Morelli, Carmen Aresta, Iacopo Chiodini
    International Journal of Molecular Sciences.2022; 23(2): 673.     CrossRef
  • Long‐term morbidity and mortality in patients with Cushing's syndrome
    Leah T. Braun, Frederick Vogel, Martin Reincke
    Journal of Neuroendocrinology.2022;[Epub]     CrossRef
  • Clinical presentation and etiology of Cushing's syndrome: Data from ERCUSYN
    Elena Valassi
    Journal of Neuroendocrinology.2022;[Epub]     CrossRef
  • Pyruvate dehydrogenase kinase 4 promotes ubiquitin–proteasome system‐dependent muscle atrophy
    Ibotombi Singh Sinam, Dipanjan Chanda, Themis Thoudam, Min‐Ji Kim, Byung‐Gyu Kim, Hyeon‐Ji Kang, Jung Yi Lee, Seung‐Hoon Baek, Shin‐Yoon Kim, Bum Jin Shim, Dongryeol Ryu, Jae‐Han Jeon, In‐Kyu Lee
    Journal of Cachexia, Sarcopenia and Muscle.2022; 13(6): 3122.     CrossRef
  • Consensus on diagnosis and management of Cushing's disease: a guideline update
    Maria Fleseriu, Richard Auchus, Irina Bancos, Anat Ben-Shlomo, Jerome Bertherat, Nienke R Biermasz, Cesar L Boguszewski, Marcello D Bronstein, Michael Buchfelder, John D Carmichael, Felipe F Casanueva, Frederic Castinetti, Philippe Chanson, James Findling
    The Lancet Diabetes & Endocrinology.2021; 9(12): 847.     CrossRef
Close layer
Original Article
Obesity and Metabolism
Increased Risk of Diabetes Development in Subjects with the Hypertriglyceridemic Waist Phenotype: A 4-Year Longitudinal Study
Ki Joong Han, Shin Yeoung Lee, Nam Hee Kim, Hyun Beom Chae, Tae Hoon Lee, Choel Min Jang, Kyung Mo Yoo, Hae Jung Park, Min Kyung Lee, Won Seon Jeon, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee
Endocrinol Metab. 2014;29(4):514-521.   Published online December 29, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.4.514
  • 4,582 View
  • 30 Download
  • 21 Web of Science
  • 21 Crossref
AbstractAbstract PDFPubReader   
Background

The hypertriglyceridemic waist (HTGW) phenotype is a simple and inexpensive screening parameter to identify people at increased risk of cardiovascular disease. We evaluated whether the HTGW phenotype predicts diabetes in urban Korean adults.

Methods

A total of 2,900 nondiabetic subjects (mean age 44.3 years), comprising 2,078 males (71.7%) and 822 females (28.3%) who underwent annual medical check-ups at our center between January 2005 and December 2009, were recruited. The subjects were divided into four groups according to baseline serum triglyceride (TG) level and waist circumference (WC): normal WC-normal TG (NWNT) level, normal WC-high TG level, enlarged WC-normal TG level, and enlarged WC-high TG (EWHT) level. High serum TG level was defined as ≥150 mg/dL and enlarged WC was defined as ≥90 cm for men and ≥85 cm for women. New cases of diabetes were determined according to questionnaires filled in by participants and the diagnostic criteria of the American Diabetes Association. Cox proportional hazards model analysis was used to assess the association of HTGW phenotype with the incidence of diabetes.

Results

A total of 101 (3.5%) new diabetes cases were diagnosed during the study period. The EWHT group had a higher incidence of diabetes (8.3%) compared with the NWNT group (2.2%). The adjusted hazard ratio for diabetes for subjects with the EWHT phenotype at baseline was 4.113 (95% confidence interval [CI], 2.397 to 7.059) after adjustment for age, and 2.429 (95% CI, 1.370 to 4.307) after adjustment for age, sex, total cholesterol, systolic blood pressure, and alcohol drinking history. It was attenuated by inclusion of baseline fasting glucose level in the model.

Conclusion

Subjects with the HTGW phenotype showed the highest risk of incident diabetes. This tool could be useful for identifying individuals at high risk of diabetes.

Citations

Citations to this article as recorded by  
  • Triglyceridemic Waist Phenotypes as Risk Factors for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Fiorella E. Zuzunaga-Montoya, Víctor Juan Vera-Ponce
    International Journal of Statistics in Medical Research.2024; 13: 19.     CrossRef
  • Association between hypertriglyceridemic-waist phenotype and circadian syndrome risk: a longitudinal cohort study
    Li-Kun Hu, Yu-Hong Liu, Kun Yang, Ning Chen, Lin-Lin Ma, Yu-Xiang Yan
    Hormones.2023; 22(3): 457.     CrossRef
  • Caracterización del fenotipo de cintura hipertrigliceridémica en pacientes con diabetes mellitus tipo 2 en España: un estudio epidemiológico
    I. Miñambres, J. Sánchez-Hernández, G. Cuixart, A. Sánchez-Pinto, J. Sarroca, A. Pérez
    Revista Clínica Española.2021; 221(10): 576.     CrossRef
  • Association of “hypertriglyceridemic waist” with increased 5-year risk of subclinical atherosclerosis in a multi-ethnic population: a prospective cohort study
    Peyman Namdarimoghaddam, Adeleke Fowokan, Karin H. Humphries, G. B. John Mancini, Scott Lear
    BMC Cardiovascular Disorders.2021;[Epub]     CrossRef
  • Characterization of the hypertriglyceridemic waist phenotype in patients with type 2 diabetes mellitus in Spain: an epidemiological study
    I. Miñambres, J. Sánchez-Hernandez, G. Cuixart, A. Sánchez-Pinto, J. Sarroca, A. Pérez
    Revista Clínica Española (English Edition).2021; 221(10): 576.     CrossRef
  • Association between Hypertriglyceridemic-Waist Phenotype and Risk of Type 2 Diabetes Mellitus in Middle-Aged and Older Chinese Population: A Longitudinal Cohort Study
    Dezhong Chen, Ziyun Liang, Huimin Sun, Ciyong Lu, Weiqing Chen, Harry H. X. Wang, Vivian Yawei Guo
    International Journal of Environmental Research and Public Health.2021; 18(18): 9618.     CrossRef
  • Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case–Control Study in Chinese Women
    Yujuan Xiang, Wenzhong Zhou, Xuening Duan, Zhimin Fan, Shu Wang, Shuchen Liu, Liyuan Liu, Fei Wang, Lixiang Yu, Fei Zhou, Shuya Huang, Liang Li, Qiang Zhang, Qinye Fu, Zhongbing Ma, Dezong Gao, Shude Cui, Cuizhi Geng, Xuchen Cao, Zhenlin Yang, Xiang Wang,
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • Hypertriglyceridemic Waist Phenotype and Lipid Accumulation Product: Two Comprehensive Obese Indicators of Waist Circumference and Triglyceride to Predict Type 2 Diabetes Mellitus in Chinese Population
    Minrui Xu, Mingtao Huang, Deren Qiang, Jianxin Gu, Yong Li, Yingzi Pan, Xingjuan Yao, Wenchao Xu, Yuan Tao, Yihong Zhou, Hongxia Ma, Ulrike Rothe
    Journal of Diabetes Research.2020; 2020: 1.     CrossRef
  • Prevalence and relationship of hypertriglyceridaemic–waist phenotype and type 2 diabetes mellitus among a rural adult Chinese population
    Yong-Cheng Ren, Yu Liu, Xi-Zhuo Sun, Bing-Yuan Wang, Yi Liu, Hu Ni, Yang Zhao, Dechen Liu, Xuejiao Liu, Dongdong Zhang, Feiyan Liu, Cheng Cheng, Leilei Liu, Xu Chen, Qionggui Zhou, Ming Zhang, Dongsheng Hu
    Public Health Nutrition.2019; 22(8): 1361.     CrossRef
  • Hypertriglyceridemic waist phenotype and abnormal glucose metabolism: a system review and meta-analysis
    Chun-Ming Ma, Xiao-Li Liu, Na Lu, Rui Wang, Qiang Lu, Fu-Zai Yin
    Endocrine.2019; 64(3): 469.     CrossRef
  • Superior Role of Waist Circumference to Body-Mass Index in the Prediction of Cardiometabolic Risk in Dyslipidemic Patients
    Ľ. Cibičková, K. Langová, H. Vaverková, J. Lukeš, N. Cibiček
    Physiological Research.2019; : 931.     CrossRef
  • Being Metabolically Healthy, the Most Responsible Factor for Vascular Health
    Eun-Jung Rhee
    Diabetes & Metabolism Journal.2018; 42(1): 19.     CrossRef
  • Letter: Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension (Endocrinol Metab 2017;32:221-9, Mohsen Janghorbani et al.)
    Eun-Jung Rhee
    Endocrinology and Metabolism.2017; 32(3): 396.     CrossRef
  • The Relationship between Hypertriglyceridemic Waist Phenotype and Early Diabetic Nephropathy in Type 2 Diabetes
    Chun-Ming Ma, Rui Wang, Xiao-Li Liu, Na Lu, Qiang Lu, Fu-Zai Yin
    Cardiorenal Medicine.2017; 7(4): 295.     CrossRef
  • The Association of Hypertriglyceridemic Waist Phenotype with Chronic Kidney Disease and Its Sex Difference: A Cross-Sectional Study in an Urban Chinese Elderly Population
    Jing Zeng, Miao Liu, Lei Wu, Jianhua Wang, Shanshan Yang, Yiyan Wang, Yao Yao, Bin Jiang, Yao He
    International Journal of Environmental Research and Public Health.2016; 13(12): 1233.     CrossRef
  • Prevalence of hypertriglyceridemic waist and association with risk of type 2 diabetes mellitus: a meta‐analysis
    Yongcheng Ren, Xinping Luo, Chongjian Wang, Lei Yin, Chao Pang, Tianping Feng, Bingyuan Wang, Lu Zhang, Linlin Li, Xiangyu Yang, Hongyan Zhang, Jingzhi Zhao, Dongsheng Hu
    Diabetes/Metabolism Research and Reviews.2016; 32(4): 405.     CrossRef
  • Utility of hypertriglyceridemic waist phenotype for predicting incident type 2 diabetes: The Isfahan Diabetes Prevention Study
    Mohsen Janghorbani, Masoud Amini
    Journal of Diabetes Investigation.2016; 7(6): 860.     CrossRef
  • βig-h3 Represses T-Cell Activation in Type 1 Diabetes
    Maeva Patry, Romain Teinturier, Delphine Goehrig, Cornelia Zetu, Doriane Ripoche, In-San Kim, Philippe Bertolino, Ana Hennino
    Diabetes.2015; 64(12): 4212.     CrossRef
  • Hypertriglyceridemic Waist – a Simple Clinical Tool to Detect Cardiometabolic Risk: Comparison With Harmonized Definition of Metabolic Syndrome
    H. VAVERKOVÁ, D. KARÁSEK, D. NOVOTNÝ, M. HALENKA, J. ORSÁG, L. SLAVÍK
    Physiological Research.2015; : S385.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Changes in Metabolic Health Status Over Time and Risk of Developing Type 2 Diabetes
    Seung-Hwan Lee, Hae Kyung Yang, Hee-Sung Ha, Jin-Hee Lee, Hyuk-Sang Kwon, Yong-Moon Park, Hyeon-Woo Yim, Moo-Il Kang, Won-Chul Lee, Ho-Young Son, Kun-Ho Yoon
    Medicine.2015; 94(40): e1705.     CrossRef
Close layer
Review Article
Polycystic Ovary Syndrome in Korean Women: Clinical Characteristics and Diagnostic Criteria.
Yeon Ah Sung
Endocrinol Metab. 2011;26(3):203-207.   Published online September 1, 2011
DOI: https://doi.org/10.3803/EnM.2011.26.3.203
  • 2,536 View
  • 42 Download
  • 3 Crossref
AbstractAbstract PDF
Polycystic ovary syndrome (PCOS) is a common disorder of premenopausal women, affecting 4 to 8% of this population. Diagnosis of PCOS lays on a combination of clinical, biological and ultrasound criteria that has been used variably worldwide. The phenotype of women with PCOS is variable depending on ethnic background and diagnostic criteria may rely on it. Fewer studies have extensively examined reproductive and metabolic characteristics and hyperandrogenism in Korean women. Despite the paucity of these studies, they are critical for the ascertainment of criteria for the diagnosis of PCOS. This review address the issues pertaining to diagnostic issues of PCOS in Korean women, specifically: reproductive and metabolic derangements and criteria for hyperandrogenism based on hirsutism and serum androgen concentrations. The prevalence (estimated) of PCOS in Korean women was 5.8%. To diagnose PCOS, the cut off value for hirsutism needs to be differently adjusted in Korean women. Regarding phenotypic characteristics of PCOS in Korean women, the various phenotypes of PCOS have the different overall morbidity (e.g. insulin resistance and hyperinsulinism, abnormal glucose metabolism and metabolic syndrome). Especially patients with oligomenorrhea/polycystic ovary and hyperandrogenism/polycystic ovary did not seem to have metabolic derangements. Thus these subgroups need to be determined if they can be classified as PCOS.

Citations

Citations to this article as recorded by  
  • Development of an integrated mobile application for lifestyle modification in women with polycystic ovarian syndrome
    Hee Kyung Choi, Seon Heui Lee, Soo Yeon Yang
    Journal of Clinical Nursing.2023; 32(1-2): 49.     CrossRef
  • Trend changes and factor analysis of endometrial hyperplasia in patients with polycystic ovarian syndrome based on the Korean National Health Insurance Database
    Bora Park, Hakmo Lee, Suyeon Park, Eun Sil Lee, Jeong Jae Lee, Young Lee, Je Hyun Seo
    BMC Women's Health.2022;[Epub]     CrossRef
  • Menstrual Cycle Patterns and the Prevalence of Premenstrual Syndrome and Polycystic Ovary Syndrome in Korean Young Adult Women
    Young-Joo Park, Hyunjeong Shin, Songi Jeon, Inhae Cho, Yae-Ji Kim
    Healthcare.2021; 9(1): 56.     CrossRef
Close layer
Original Article
Phenotypic Variation of Polycystic Ovary Syndrome.
Gun Woo Pyun, Young Ju Choi, Hyejin Lee, Jee Young Oh, Young Sun Hong, Yeon Ah Sung, Hye Won Chung
J Korean Endocr Soc. 2007;22(5):326-331.   Published online October 1, 2007
DOI: https://doi.org/10.3803/jkes.2007.22.5.326
  • 1,836 View
  • 23 Download
  • 4 Crossref
AbstractAbstract PDF
BACKGROUND
Polycystic ovary syndrome (PCOS) is a common disorder in premenopausal women, but there has been little agreement on its diagnostic criteria due to its uncertain pathogenesis and the heterogeneity of symptoms. This study was performed in order to assess the differences in clinical, metabolic, and hormonal characteristics of women in the PCOS subgroups defined by ESHRE criteria. METHODS: Subjects were divided into four PCOS subgroups based on ESHRE criteria. The grouping groupings included: 1) hyperandrogenism, oligomenorrhea, and polycystic ovary morphology (HA + OM + PCO); 2) hyperandrogenism and oligomenorrhea (HA + OM); 3) hyperandrogenism and polycystic ovary morphology (HA + PCO); and 4) oligomenorrhea and polycystic ovary morphology (OM + PCO). Reproductive hormones and metabolic profiles were measured. RESULTS: Of the total number of subjects, 60 (40%) fulfilled the criteria for HA + OM + PCO, 50 (33%) for HA + OM, 11 (7%) for HA + PCO, and 30 (20%) for OM + PCO. There were no significant differences in clinical or metabolic features among the groups, except for LH, total cholesterol, and HDL cholesterol. CONCLUSION: In this population defined by ESHRE criteria, 73% of the patients met the former NIH definition for PCOS. Different phenotypes of PCOS cases were clinically or biochemically similar. Whether these women have an increased risk of infertility or metabolic complications remains to be determine.

Citations

Citations to this article as recorded by  
  • Epidemiology and Diagnostic Criteria of Polycystic Ovary Syndrome
    Hyejin Lee, Yeon-Ah Sung
    The Journal of Korean Diabetes.2015; 16(3): 189.     CrossRef
  • Hyperandrogenism in Women: Polycystic Ovary Syndrome
    Yeon-Ah Sung
    Hanyang Medical Reviews.2012; 32(4): 197.     CrossRef
  • Polycystic Ovary Syndrome in Korean Women: Clinical Characteristics and Diagnostic Criteria
    Yeon-Ah Sung
    Endocrinology and Metabolism.2011; 26(3): 203.     CrossRef
  • Clinical Manifestation of Polycysticv Ovary Syndrome
    Yu-Bae Ahn
    Journal of Korean Endocrine Society.2007; 22(5): 323.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism